Exyte Pharmaplan is one of the leading pharmaceutical consulting and engineering companies in Europe. We specialize in integrated and holistic planning and realization of world-class pharmaceutical research and production facilities.
Our talented teams shape the future of our industry, specializing in areas such as project management, process engineering, GMP, laboratory planning, architecture, building services, automation, and digital factories.
We operate under the umbrella of Exyte, a design, engineering, and construction company that delivers some of the most advanced projects in high-tech industries such as biopharma and life sciences, semiconductors, batteries, and data centers.
From initiation to construction to handover, we undertake projects of all sizes for our clients. Want to explore an exciting career with us? Join us and become part of the Pharmaplan mission!
Fusion Pharmaceuticals is a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines. Employing a proprietary Fast-Clear linker technology, Fusion connects alpha particle emitting isotopes to antibodies and other targeting molecules in order to selectively deliver the alpha emitting payloads to tumors. Fusion's lead program, FPI-1434, is currently in a Phase 1 clinical trial.
Fusion is headquartered in Hamilton, ON, with offices in Boston, MA.
Theratechnologies is a specialty biopharmaceutical company focused on the commercialization of innovative therapies that have the potential to redefine standards of care.
We currently market prescription products for people with HIV in the United States. Our research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, oncology and rare and niche populations.